DRSP, an autophagy activator, currently has no human clinical trials available.Spiro was shown to rescue insulin resistance in humans with chronic kidney disease, and reversed glucose intolerance in mice possibly by activating autophagy (Hosoya et al., 2015). The gene discussed is PNN; the disease is chronic kidney disease.